eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.17
-0.01 (-0.17%)
At close: Aug 28, 2026, 4:00 PM EDT
7.25
+0.08 (1.15%)
After-hours: Aug 28, 2026, 7:30 PM EDT
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $66.53 million as of August 28, 2026. Its market cap has decreased by -18.23% in one year.
Market Cap
66.53M
Enterprise Value
61.96M
1-Year Change
-18.23%
Ranking
Category
Stock Price
$7.17
ChartMarket Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $66.53M, a decrease of -5.37%. That is a compound annual growth rate of -3.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 66.53M | -27.23% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 70.12M |
| Eloxx Pharmaceuticals | 70.11M |
| Spero Therapeutics | 69.88M |
| Rein Therapeutics | 69.53M |
| BioStem Technologies | 68.90M |
| PMV Pharmaceuticals | 68.16M |
| Champions Oncology | 68.08M |
| INmune Bio | 67.44M |